These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33550641)

  • 1. Incidence of von Willebrand disease in Denmark, 1995-2016: A cohort study.
    Laursen ASD; Rasmussen TB; Chiu GR; Brouwer ES; Poulsen LH; Mikkelsen EM
    Haemophilia; 2021 Mar; 27(2):277-282. PubMed ID: 33550641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Von Willebrand Disease: Gaining a global perspective.
    O'Sullivan JM; Tootoonchian E; Ziemele B; Makris M; Federici AB; Khayat Djambas C; El Ekiaby M; Rotellini D; Sidonio RF; Iorio A; Coffin D; Pierce GF; Stonebraker J; James PD; Lavin M
    Haemophilia; 2023 Jul; 29(4):1104-1112. PubMed ID: 37216656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosing von Willebrand disease].
    Vojdeman FJ; Philips M; Funding E; Gøtze JP
    Ugeskr Laeger; 2019 Apr; 181(16):. PubMed ID: 31036151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand disease: a clinical and laboratory study of sixty-five patients.
    Chen YC; Yang L; Cheng SN; Hu SH; Chao TY
    Ann Hematol; 2011 Oct; 90(10):1183-90. PubMed ID: 21643680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease.
    Makris M; Federici AB; Mannucci PM; Bolton-Maggs PHB; Yee TT; Abshire T; Berntorp E
    Haemophilia; 2015 May; 21(3):338-342. PubMed ID: 25381842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of von Willebrand disease in Western Mexico.
    Zavelia Padilla-Romo MG; Ornelas-Ricardo D; Luna-Záizar H; Rebeca Jaloma-Cruz A
    Haemophilia; 2021 Jan; 27(1):e78-e87. PubMed ID: 33215800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence rates of von Willebrand disease among people receiving care in specialized treatment centres in the United States.
    Michael Soucie J; Miller CH; Byams VR; Payne AB; Abe K; Sidonio RF; Kouides PA
    Haemophilia; 2021 May; 27(3):445-453. PubMed ID: 33780098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics, complications, and sites of bleeding among infants and toddlers less than 2 years of age with VWD.
    Dupervil B; Abe K; O'Brien SH; Oakley M; Kulkarni R; Thornburg CD; Byams VR; Soucie JM
    Blood Adv; 2021 Apr; 5(8):2079-2086. PubMed ID: 33877293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reported prevalence of von Willebrand disease worldwide in relation to income classification.
    Stonebraker JS; Iorio A; Lavin M; Rezende SM; Srivastava A; Pierce GF; Coffin D; Tootoonchian E; Makris M
    Haemophilia; 2023 Jul; 29(4):975-986. PubMed ID: 37276350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of von Willebrand disease in Spain.
    Batlle J; Perez-Rodriguez A; Pinto JC; Fraga EL; Rodriguez-Trillo Tch A; Fernanda Lopez-Fernandez M
    Semin Thromb Hemost; 2011 Jul; 37(5):503-10. PubMed ID: 22102193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of von Willebrand Disease in the South Moravian Population (Czech Republic): Results from the BRNO-VWD Study.
    Vangenechten I; Smejkal P; Zapletal O; Michiels JJ; Berneman Z; Zavrelova J; Blatný J; Penka M; Gadisseur A
    Thromb Haemost; 2019 Apr; 119(4):594-605. PubMed ID: 30722078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype.
    Kempers EK; van Kwawegen CB; de Meris J; Schols SEM; van Galen KPM; Meijer K; Cnossen MH; van der Bom JG; Fijnvandraat K; Eikenboom J; Atiq F; Leebeek FWG;
    Haemophilia; 2022 Mar; 28(2):278-285. PubMed ID: 34964530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.
    Kalot MA; Husainat N; El Alayli A; Abughanimeh O; Diab O; Tayiem S; Madoukh B; Dimassi AB; Qureini A; Ameer B; Eikenboom JCJ; Giraud N; McLintock C; McRae S; Montgomery RR; O'Donnell JS; Scappe N; Sidonio RF; Brignardello-Petersen R; Flood VH; Connell NT; James PD; Mustafa RA
    Blood Adv; 2022 Jan; 6(1):62-71. PubMed ID: 34610118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sixth Åland Island Conference on von Willebrand disease.
    Berntorp E; Trakymienė SS; Federici AB; Holstein K; Corrales-Medina FF; Pierce GF; Srivastava A; Prondzinski MVD; Johnsen JM; Zupan IP; Halimeh S; Nummi V; Roberts JC
    Haemophilia; 2022 Jul; 28 Suppl 5(Suppl 5):3-15. PubMed ID: 35861919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Closing the gap - detection of clinically relevant von Willebrand disease in emergency settings through an improved algorithm based on rotational Thromboelastometry.
    Topf HG; Strasser ER; Breuer G; Rascher W; Rauh M; Fahlbusch FB
    BMC Anesthesiol; 2019 Jan; 19(1):10. PubMed ID: 30630422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Perioperative Management of Orthotopic Cardiac Transplantation in a Pediatric Patient With Concurrent Congenital von Willebrand Disease and Acquired von Willebrand Syndrome Using Recombinant von Willebrand Factor.
    Batsuli G; Zimowski KL; Carroll R; White MH; Woods GM; Meeks SL; Sidonio RF
    J Cardiothorac Vasc Anesth; 2022 Mar; 36(3):724-727. PubMed ID: 33618961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of female family members of von Willebrand disease patients: utility of a modified screening tool in a high-risk population.
    Faiz AS; Kaveney A; Guo S; Murphy S; Philipp CS
    Haemophilia; 2017 Sep; 23(5):736-742. PubMed ID: 28181360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fifth Åland Island conference on von Willebrand disease.
    Berntorp E; Ågren A; Aledort L; Blombäck M; Cnossen MH; Croteau SE; von Depka M; Federici AB; Goodeve A; Goudemand J; Mannucci PM; Mourik M; Önundarson PT; Rodeghiero F; Szántó T; Windyga J
    Haemophilia; 2018 May; 24 Suppl 4():5-19. PubMed ID: 29687935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.